Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05216029 · ClinicalTrials.gov registry record · NA

Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma

A NA study of Sarcoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT05216029 is a NA study of Sarcoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 92 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05216029, a NA study of Sarcoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard" may help patients understand the disease better and help the patient's medical team manage their care more efficiently. The oncology dashboard tool may help patients understand the disease better and may help improve the efficiency of their medical care.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Informational Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2015-10-01
Est. Completion 2027-02-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05216029

The ClinicalTrials.gov registry entry for NCT05216029 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (90% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT05216029 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05216029 about?

NCT05216029 is a clinical study titled "Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma". This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard" may help patients understand the disease better and help the patient's medical team manage their c...

What is the current status of trial NCT05216029?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2015-10-01. Estimated completion is 2027-02-02.

What conditions does trial NCT05216029 study?

This clinical trial studies the following conditions: Sarcoma.

What interventions are being tested in trial NCT05216029?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT05216029?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05216029 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.